21 January 2025
21 January 2025
Over the past decade, interest in psychedelics—including psilocybin, LSD, and MDMA—as treatments for psychiatric disorders has grown exponentially among scientists, mental health professionals, the media, and the public.
16 January 2025
During periods of low energy—such as intermittent fasting or exercise—immune cells step in to regulate blood sugar levels, acting as the “postman” in a previously unknown three-way conversation between the nervous, immune and hormonal systems. These findings open up new approaches for managing conditions like diabetes, obesity, and cancer.
20 January 2025 – 12:00
Champalimaud Foundation Auditorium
Conventional Dendritic Cells – Ecology, Diversity, and Functio
Carlos Minutti (Immunoregulation Lab)
Moderator: Cristina João (Myeloma Lymphoma Research Group)
15 Jan. 2025
The Champalimaud Foundation Breast Cancer Research Program - is dedicated to advancing the understanding, prevention, and treatment of breast cancer. The program integrates cutting-edge research with community engagement and education to improve outcomes for those affected by breast cancer.
15 Jan. 2025
The Breast Cancer Research Program at the Champalimaud Foundation is dedicated to advancing the understanding, prevention, and treatment of breast cancer. The program integrates cutting-edge research with community engagement and education to improve outcomes for those affected by breast cancer.
14 January 2025
Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 and 20, during times of rapid bone growth. Although rare, it has a significant impact on young people and their families as treatment can require surgery or amputation. The cancer also has the potential to spread to other organs, most commonly the lungs. Because osteosarcoma is so genomically complex, it has been challenging to identify what genetic mutations drive the disease.